Revenue

With a fresh $8.5M in funding and a powerful ally in KYMCO Capital, Sleek EV is accelerating its mission to dominate Southeast Asia's EV market.

A surprise move by a joint venture partner to exercise pre-emption rights has thrown Maurel & Prom’s major Angolan oil field acquisition into uncertainty.

LG Energy Solution acquires Stellantis's stake in Canada's NextStar battery plant, signaling a major strategic shift towards the energy storage market.

One Port St. opens with 5-star amenities, but its arrival in the creative Northern Quarter raises questions about regeneration and the city's future.

With a new industrial leader, Lithium de France is accelerating its ambitious plan to supply one-third of the nation's lithium from geothermal sources.

Vietnam's e-commerce sellers get a boost as Cake Digital Bank and Visa launch a new solution to streamline complex international payments.

ACG becomes the first pharma packaging firm in the WEF's elite Lighthouse Network, using AI to slash defects and energy use, setting a new global standard.

With only 20% of Aussie SMEs insured against cyber threats, Cowbell and Zurich launch an AI-powered platform to simplify and expand coverage.

A new partnership between Finloop and EX.IO aims to build a compliant RWA ecosystem in Hong Kong, unlocking global liquidity for professional investors.

A $41.25M deal for a new cottage-style community in Monroe, NC, highlights a growing housing trend and an investor's bet on 'affordable' suburban living.

Recognized as a Major Player by IDC, South Korea's SK shieldus leverages its AI platform to expand globally and serve businesses of all sizes.

Radisson Hotel Group signs a new RED hotel for Queenstown, signaling a strategic shift in the adventure capital's booming, high-value tourism market.

MGM Resorts moved its earnings date up, and now we know why. The gaming giant beat Wall Street estimates with powerful results from BetMGM and Macau.

Former Senator Joe Manchin and pharma exec Heather Manchin join BlinkRx, bringing political and industry muscle to the fight for affordable medicine.

Investors brace for South Bow's year-end results, seeking answers on pipeline repairs, new project cash flows, and its strategy in a shifting energy market.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

With its Q4 results announcement imminent, specialty insurer Trisura is under scrutiny to prove it can sustain growth amid market pressures and investor concerns.

Facing a stock slump and operational woes, Clorox leaders must deliver a convincing turnaround plan at the upcoming CAGNY investor conference.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

Amid financial headwinds, specialty chemicals firm Orion S.A. will pitch its strategic pivot to the high-growth EV and sustainable materials markets.